Literature DB >> 21245156

Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring.

James H McMahon1, Michael R Jordan, Karen Kelley, Silvia Bertagnolio, Steven Y Hong, Christine A Wanke, Sharon R Lewin, Julian H Elliott.   

Abstract

Prescription or pill-based methods for estimating adherence to antiretroviral therapy (ART), pharmacy adherence measures (PAMs), are objective estimates calculated from routinely collected pharmacy data. We conducted a literature review to evaluate PAMs, including their association with virological and other clinical outcomes, their efficacy compared with other adherence measures, and factors to consider when selecting a PAM to monitor adherence. PAMs were classified into 3 categories: medication possession ratio (MPR), pill count (PC), and pill pick-up (PPU). Data exist to recommend PAMs over self-reported adherence. PAMs consistently predicted patient outcomes, but additional studies are needed to determine the most predictive PAM parameters. Current evidence suggests that shorter duration of adherence assessment (≤ 6 months) and use of PAMs to predict future outcomes may be less accurate. PAMs which incorporate the number of days for which ART was prescribed without the counting of remnant pills, are reasonable minimum-resource methods to assess adherence to ART.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21245156      PMCID: PMC3060901          DOI: 10.1093/cid/ciq167

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  55 in total

1.  Disease progression, adherence, and response to protease inhibitor therapy for HIV infection in an Urban Veterans Affairs Medical Center.

Authors:  K Maher; N Klimas; M A Fletcher; V Cohen; C M Maggio; J Triplett; R Valenzuela; G Dickinson
Journal:  J Acquir Immune Defic Syndr       Date:  1999-12-01       Impact factor: 3.731

2.  Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team).

Authors:  D Descamps; P Flandre; V Calvez; G Peytavin; V Meiffredy; G Collin; C Delaugerre; S Robert-Delmas; B Bazin; J P Aboulker; G Pialoux; F Raffi; F Brun-Vézinet
Journal:  JAMA       Date:  2000-01-12       Impact factor: 56.272

3.  Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults.

Authors:  Jean B Nachega; Michael Hislop; David W Dowdy; Melanie Lo; Saad B Omer; Leon Regensberg; Richard E Chaisson; Gary Maartens
Journal:  J Acquir Immune Defic Syndr       Date:  2006-09       Impact factor: 3.731

4.  Assessing the utility of a community pharmacy refill record as a measure of adherence and viral load response in patients infected with human immunodeficiency virus.

Authors:  John F Inciardi; Andrew L Leeds
Journal:  Pharmacotherapy       Date:  2005-06       Impact factor: 4.705

5.  Use of a prescription-based measure of antiretroviral therapy adherence to predict viral rebound in HIV-infected individuals with viral suppression.

Authors:  V Cambiano; F C Lampe; A J Rodger; C J Smith; A M Geretti; R K Lodwick; J Holloway; M Johnson; A N Phillips
Journal:  HIV Med       Date:  2009-12-03       Impact factor: 3.180

Review 6.  Preventing HIV antiretroviral resistance through better monitoring of treatment adherence.

Authors:  David R Bangsberg
Journal:  J Infect Dis       Date:  2008-05-15       Impact factor: 5.226

7.  The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time.

Authors:  Viviane D Lima; Richard Harrigan; David R Bangsberg; Robert S Hogg; Robert Gross; Benita Yip; Julio S G Montaner
Journal:  J Acquir Immune Defic Syndr       Date:  2009-04-15       Impact factor: 3.731

8.  Evaluating adherence to highly active antiretroviral therapy with use of pill counts and viral load measurement in the drug resources enhancement against AIDS and malnutrition program in Mozambique.

Authors:  Massimo Magnano San Lio; Riccardo Carbini; Paola Germano; Giovanni Guidotti; Sandro Mancinelli; Noorjehan Abdul Magid; Pasquale Narciso; Leonardo Palombi; Elsa Renzi; Ines Zimba; Maria Cristina Marazzi
Journal:  Clin Infect Dis       Date:  2008-05-15       Impact factor: 9.079

9.  Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness.

Authors:  David R Bangsberg; Edward P Acosta; Reena Gupta; David Guzman; Elise D Riley; P Richard Harrigan; Neil Parkin; Steven G Deeks
Journal:  AIDS       Date:  2006-01-09       Impact factor: 4.177

10.  Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine- or efavirenz-based antiretroviral therapy.

Authors:  Jean-Jacques Parienti; Véronique Massari; Diane Descamps; Astrid Vabret; Elisabeth Bouvet; Bernard Larouzé; Renaud Verdon
Journal:  Clin Infect Dis       Date:  2004-04-14       Impact factor: 9.079

View more
  72 in total

Review 1.  A proposal for quality standards for measuring medication adherence in research.

Authors:  Ann Bartley Williams; K Rivet Amico; Carol Bova; Julie A Womack
Journal:  AIDS Behav       Date:  2013-01

2.  Implementation Science Using Proctor's Framework and an Adaptation of the Multiphase Optimization Strategy: Optimizing a Financial Incentive Intervention for HIV Treatment Adherence in Tanzania.

Authors:  Laura Packel; Carolyn Fahey; Prosper Njau; Sandra I McCoy
Journal:  J Acquir Immune Defic Syndr       Date:  2019-12       Impact factor: 3.731

3.  Barriers and facilitators of antiretroviral therapy adherence in rural Eastern province, Zambia: the role of household economic status.

Authors:  Rainier Masa; Gina Chowa; Victor Nyirenda
Journal:  Afr J AIDS Res       Date:  2017-06-22       Impact factor: 1.300

4.  Pharmacy and self-report adherence measures to predict virological outcomes for patients on free antiretroviral therapy in Tamil Nadu, India.

Authors:  James H McMahon; Anand Manoharan; Christine A Wanke; Shoba Mammen; Hepsibah Jose; Thabeetha Malini; Tony Kadavanu; Michael R Jordan; Julian H Elliott; Sharon R Lewin; Dilip Mathai
Journal:  AIDS Behav       Date:  2013-07

5.  What we know and what we do not know about factors associated with and interventions to promote antiretroviral adherence.

Authors:  Sharon Mannheimer; Yael Hirsch-Moverman
Journal:  Curr Infect Dis Rep       Date:  2015-04       Impact factor: 3.725

Review 6.  Health Technology-Enabled Interventions for Adherence Support and Retention in Care Among US HIV-Infected Adolescents and Young Adults: An Integrative Review.

Authors:  Ann-Margaret Dunn Navarra; Marya Viorst Gwadz; Robin Whittemore; Suzanne R Bakken; Charles M Cleland; Winslow Burleson; Susan Kaplan Jacobs; Gail D'Eramo Melkus
Journal:  AIDS Behav       Date:  2017-11

7.  A systematic review of psychological correlates of HIV testing intention.

Authors:  Michael Evangeli; Krissie Ferris; Natalie M Kenney; Laura L E Baker; Bethanie Jones; Abigail L Wroe
Journal:  AIDS Care       Date:  2017-07-07

8.  Chemokine (C-C motif) receptor 5 -2459 genotype in patients receiving highly active antiretroviral therapy: race-specific influence on virologic success.

Authors:  Rajeev K Mehlotra; Vinay K Cheruvu; Melinda J Blood Zikursh; Rebekah L Benish; Michael M Lederman; Robert A Salata; Barbara Gripshover; Grace A McComsey; Michelle V Lisgaris; Scott Fulton; Carlos S Subauste; Richard J Jurevic; Chantal Guillemette; Peter A Zimmerman; Benigno Rodriguez
Journal:  J Infect Dis       Date:  2011-07-15       Impact factor: 5.226

9.  Warfarin therapy in the HIV medical home model: low rates of therapeutic anticoagulation despite adherence and differences in dosing based on specific antiretrovirals.

Authors:  Albert M Anderson; Tanea Chane; Manish Patel; Shuo Chen; Wenqiong Xue; Kirk A Easley
Journal:  AIDS Patient Care STDS       Date:  2012-06-28       Impact factor: 5.078

10.  Correlates of non-adherence to antiretroviral therapy in a cohort of HIV-positive drug users receiving antiretroviral therapy in Hanoi, Vietnam.

Authors:  M R Jordan; Y Obeng-Aduasare; H Sheehan; S Y Hong; N Terrin; D V Duong; N V Trung; C Wanke; N V Kinh; A M Tang
Journal:  Int J STD AIDS       Date:  2013-12-18       Impact factor: 1.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.